DARE
Dare Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.77
+3.05%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $2.0M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.30
- Revenue actual
- —
- Revenue estimate
- $1.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +44.7%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.30 | -$0.20 | Beat 32.59% | — |
| May 14, 2026 | -$0.33 | -$0.20 | Beat 39.39% | $152.5K |
| Mar 26, 2026 | -$0.24 | -$0.02 | Beat 91.67% | $1.0M |
| Nov 13, 2025 | -$0.33 | -$0.28 | Beat 15.15% | — |
| Aug 14, 2025 | -$0.55 | -$0.45 | Beat 18.18% | -$21.2K |
| Mar 31, 2025 | -$0.66 | -$0.64 | Beat 3.03% | -$63.6K |
| Nov 14, 2024 | -$0.60 | -$0.55 | Beat 8.33% | $41.7K |
| Nov 9, 2023 | -$1.20 | -$1.08 | Beat 10.00% | $1.0M |
| Aug 10, 2023 | -$1.20 | -$1.20 | In line | — |
| May 11, 2023 | -$1.20 | -$1.08 | Beat 10.00% | — |
| Nov 10, 2022 | -$1.32 | -$0.96 | Beat 27.27% | — |
| May 12, 2022 | -$1.68 | -$1.20 | Beat 28.57% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026